Product Details

Veratram is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Tramadol Hydrochloride for use as a centrally acting analgesic through the intramuscular (I.M.) or intravenous (I.V.) route. As a result, it offers effective relief from moderate to severe pain across a range of clinical settings.

The injection contains:

• Tramadol Hydrochloride BP (equivalent to Tramadol) – A centrally acting analgesic that acts on opioid receptors while also inhibiting the reuptake of serotonin and noradrenaline. Consequently, it delivers dual-mechanism pain relief with a comparatively lower risk of respiratory depression than traditional opioids.

Physicians use Veratram for the management of moderate to severe pain, including post-operative pain, trauma-related pain, and pain associated with medical procedures. In addition, its dual-route (I.M./I.V.) formulation allows flexible administration based on clinical need. Because of this profile, Veratram suits hospitals, surgical units, and pain management settings where reliable, centrally acting analgesia is required.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the dual-route (I.M./I.V.) formulation offers flexible clinical use
• Furthermore, each vial delivers precise, validated dosage accuracy
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies